among hemophilia a patients , htlv iii antibodies were demonstrated in 40 of 48 ( 83 % ) cases treated with american factor viii concentrate and in 17 of 29 ( 59 % ) cases treated with both american and swedish concentrates but in none of 13 cases treated exclusively with swedish factor viii .
C0019069
hemophilia
C0015506
factor viii